New sulphonamide and carboxamide derivatives of acyclic C-nucleosides of triazolo-thiadiazole and the thiadiazine analogues. Synthesis, anti-HIV, and antitumor activities. Part 2

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 9, 2008, Pages 1034-1044

  Al Masoudi, Najim A ^a,c   Al Soud, Yaseen A ^b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b AL AL BAYT UNIVERSITY   (Jordan)

^c NONE   (Germany)

Author keywords

Acyclic C nucleosides; Anti HIV activity; Carboxamides; Microwave assisted synthesis; Sulphonamides; Triazolo thiadiazoles and thiadiazines

Indexed keywords

3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL) 6 (4 N PHENYLFURAN 2 CARBOXAMIDO) [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOLE; 3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL) 6 (4 N PHENYLQUINOLON 4 CARBOXAMIDO) [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOLE; 3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL) 6 (4 N PHENYLTHIOPHENE 2 CARBOXAMIDO)[1,2,4] TRIAZOLO[3,4 B][1,3,4]THIADIAZOLE; 3 (DEXTRO RIBO TETRITOL 1 YL) 6 PHENYL [1,2,4] TRIAZOLO[3,4 B][1,3,4]THIADIAZINE; 3 (DEXTRO RIBO TETRITOL 1 YL) [1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZINE 6 CARBOXYLATE; 6 (2 FLUORO 4 N PHENYLBENZAMIDO) 3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL)[1,2,4] TRIAZOLO[3,4 B][1,3,4]THIADIAZOLE; 6 (2,4 DICHLOROPHENYL) 3 (DEXTRO RIBO TETRITOL 1 YL) [1,2,4] TRIAZOLO[3,4 B][1,3,4]THIADIAZINE; AMIDE; N [4 {3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL)[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 6 YL}PHENYL] 4 CHLOROBENZENENSULPHONAMIDE; N [4 {3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL)[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 6 YL}PHENYL] 4 METHYLBENZENENSULPHONAMIDE; N [4 {3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL)[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 6 YL}PHENYL] 4 NITROBENZENENSULPHONAMIDE; N [4 {3 (1,2 O ISOPROPYLIDENE DEXTRO RIBO TETRITOL 1 YL)[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZOL 6 YL}PHENYL]FURANSULPHONAMIDE; SULFONAMIDE; THIADIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HYDROLYSIS; IN VITRO STUDY; MICROWAVE IRRADIATION; NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG DESIGN; HUMANS; HYDROCARBONS, ACYCLIC; MICROWAVES; MOLECULAR STRUCTURE; NUCLEOSIDES; SULFONAMIDES; T-LYMPHOCYTES; THIADIAZINES; THIADIAZOLES;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 49749100422     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802271771     Document Type: Article

References (26)

1. Schaeffer, H.J.; Beauchamp, L.; de Miranda, P.; Elion, G.B.; Bauer, D.J.; Collins, P. 9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group. Nature 1978, 272, 583-585.
2. (a) Fiddian, A.P.; Brigden, D.; Yeo, J.M.; Hickmott, E.A. Acyclovir: An update of the clinical applications of this antiherpes agent. Antiviral Res. 1984, 4, 99-117.
3. b) Dolin, R. Antiviral chemotherapy and chemoprophylaxis. Science 1985, 227, 1296-1303.
4. De Clercq, E.; Descamps, J.; De Somer, P.; Holy, A. (S)-9-(2,3- Dihydroxypropyl) adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity. Science 1978, 200, 563-565.
5. Holy, A. Phosphonylmethyl analogs of nucleotides and their derivatives: chemistry and biology. Nucleosides Nucleotides 1987, 6, 147-155, references cited therein.
6. Keller, P.M.; Fyfe, J.A.; Beauchamp, L.; Lubbers, C.M.; Furman, P.A.; Schaeffer, H. J.; Elion, G.B. Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. Biochem. Pharmacol. 1981, 30, 3071-3077.
7. Larsson, A.; Alenius, S.; Johansson, N.-G.; Oberg, B. Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res. 1983, 3, 77-86.
8. Barrio, J.R.; Bryant, J.D.; Keyser, G.E. A direct method for the preparation of 2-hydroxyethoxymethyl derivatives of guanine, adenine, and cytosine. J. Med. Chem. 1980, 23, 572-574.
9. Ewiss, N.F.; Bahajaj, A.A. Synthesis and antimicrobial activity of some 7H-s-triazolo[3,4-b][1,3,4]thiadiazine and s-triazolo[3,4- b]thiadiazoles derivatives. J. Heterocycl. Chem. 1987, 24, 1173-1182.
10. Chadha, V.K.; Ranwa, N.S.; Dadheech, P.K. Synthesis and screening of biological activity of triazolothiadiazines and triazolothiadiazoles. J. Phytol. Res. 1998, 11, 201-202.
11. Sakata, M.; Shirakawa, Y.; Kamata, N.; Sakaguchi, Y.; Nishino, H.; Ouyang, J.; Kurosawa, K. Synthesis of thiazole, oxazole and heterocyclic ring-substituted 1,2-dioxanes. J. Heterocycl. Chem. 2000, 37, 269-271.
12. Nadkarni, B.A.; Kamat, V.R.; Khadse, B.G. Synthesis and anthelmintic activity of 3,6-disubstituted -7H-s-triazolo[3,4-b][1,3,4] thiadiazines. Arzneim. Forsch. 2001, 51, 569-573.
13. Holla, B.S.; Akberali, P.M.; Shivananda, M.K. Studies on nitrophenylfuran derivatives: part XII. synthesis, characterization, antibacterial and antiviral activities of some nitrophenyl-furfurylidene-1,2,4-triazolo[3,4-b]-1,3, 4-thiadiazines. Farmaco 2001, 56, 919-927.
14. Hui, X.P.; Zhang, Y.; Xu, P.F.; Wang, Q.; Zhang, Q.; Zhang, Z.Y. Syntheses and antibacterial activities of novel 3-substituted-6-(4-chlorophenyl) -7-(1H-1,2,4-triazole-1-yl)-1′,2′,4′-triazolo [3,4-b]-1″,3″,4″-thiadiazines. Chin. J. Org. Chem. 2005, 25, 700-704.
15. Holla, B.S.; Rao, B.S.; Sarojini, B.K.; Akberali, P.M.; Kumari, N.S. Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents. Eur. J. Med. Chem. 2006, 41, 657-663.
16. Holla, B.S.; Rao, B.S.; Shridhara, K.; Akberali, P.M. Studies on arylfuran derivatives Part XI. Synthesis, characterisation and biological studies on some Mannich bases carrying 2, 4-dichlorophenylfurfural moiety. Farmaco 2000, 55, 338-344.
17. Demirbas, N.; Demirbas, A.; Karaoglu, S.A.; Çelik, E. Synthesis and antimicrobial activities of some new [1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles and 1,2,4]triazolo[3,4-b][1,3,4]thiadiazones. ARKIVOC 2005, 75-91.
18. Al-Soud, Y.A.; Al-Masoudi, N.A.; De Clercq, E.; Pannecouque, C. Microwave-assisted synthesis and anti-HIV activity of new acyclic C-nucleosides of 3-(D-ribo- tetritol-1-yl)-5-mercapto-1,2,4- triazoles. Part. 1. 2008.
19. Green, J.R.; Troupin, A.S.; Halperm, L.M.; Friel, P.; Kanarek, , Sulthiame, P. Evaluation as an anticonvulsant. Epilepsia 1974, 15, 329-349.
20. Petri, Jr., W.A. Antimicrobial agents, in Goodman and Gilman's Pharmacological Basis of Therapeutics, eds. J.G. Hardman and L.E. Limbird, McGraw Hill, New York, 2001, 10th ed., pp. 1171-1188.
21. Beale, Jr., J.M. Anti infective agents, in Wilson and Gisvold's Text Book of Organic Medicinal and Pharmaceutical Chemistry, eds. J.H. Block and J.M. Beale, Jr., , Lippincott William and Wilkins, Philadelphia, 2004, 11th ed. pp. 217-281.
22. Willker, W.; Leibfritz, D.; Kerssebaum, R.; Bermel, W. Gradient selection in inverse heteronuclear correlation spectroscopy. Mag. Reson. Chem. 1993, 31, 287-292.
23. Bodenhausen, G.; Ruben, D.J. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 1980, 69, 185-189.
24. Young, S.D.; Britcher, S.F.; Tran, L.O.; Payne, L.S.; Lumma, W.C.; Lyle, T.A.; Huff, J. R.; Anderson, P.S.; Olsen, D.B.; Carroll, S.S. L-743,726 (DMP-266): A novel, highly potent non-nucleoside inhibitor of the human immunodeficiency-virus type-1 reverse transcriptase. Antimicrob. Agents Chemother. 1995, 39, 2602-2605.
25. Fujiwara, T.; Sato, A.; El-Farrash, M.; Miki, S.; Abe, K.; Isaka, Y.; Kodama, M.; Wu, Y.; Chen, L.B.; Harada, H.; Sugimoto, H.; Hatanaka, M.; Hinuma, Y. S-1153 Inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 1998, 42, 1340-1345.
26. Alley, M.C.; Scudiero, D.A.; Monks, A.; Hursey, M.L.; Czerwinski, M.J.; Fine, D.L.; Abbott, B.J.; Mayo, J.G.; Schoemaker, R.H.; Boyd, M.R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.